Murray State's Digital Commons - Scholars Week: Improving Perioperative Outcomes and Reducing Opioid Use with Dexmedetomidine as a Neuraxial Adjunct: Provider Education
 

SNHP | Nurse Anesthesia DNP Project Presentations

Improving Perioperative Outcomes and Reducing Opioid Use with Dexmedetomidine as a Neuraxial Adjunct: Provider Education

Presenter Information

Christina CokeFollow

Academic Level at Time of Presentation

Graduate

Major

Nurse Anesthesia

List all Project Mentors & Advisor(s)

Dr. Tonia Mailow

Presentation Format

Poster Presentation

Abstract/Description

Background

Inadequate post-operative pain management and the rising use of opioids as a remedy are some of the most significant barriers to optimal perioperative outcomes for many patients. Using Dexmedetomidine as a neuraxial adjunct to optimize post-operative pain and reduce opioid use is one of the latest developments in anesthesia to combat this issue.

Objective

This quality improvement project aimed to develop an educational intervention to increase CRNA awareness about the growing anesthetic technique of neuraxial Dexmedetomidine, improving their knowledge and comfort in adopting a technique that reduces opioid consumption.

Design

CRNAs completed a pre-survey to assess their knowledge of using Dexmedetomidine as a neuraxial adjunct. Participants then attended educational sessions outlining the latest evidence supporting the practice. A posttest followed the sessions to assess changes in knowledge and the likelihood of CRNAs incorporating this newer technique within their practice.

Results

CRNAs demonstrated an increase in their knowledge about the mechanism through which neuraxial Dexmedetomidine improves the perioperative experience and reduces opioid consumption. Most participants reported a high likelihood of adopting this technique within their practice.

Conclusion

Current literature suggests that Dexmedetomidine as a neuraxial adjunct has the potential to transform perioperative experiences as we move to opioid-sparing techniques. The educational sessions to disseminate the upcoming technique effectively increased the awareness and practice knowledge of all the learners involved to continue improving patient outcomes.

KEYWORDS: intrathecal Dexmedetomidine, epidural Dexmedetomidine, opioid-sparing analgesia, provider education

Fall Scholars Week 2024 Event

Other (Please write in)

Other Scholars Week Event

Nurse Anesthesia Program

This document is currently not available here.

Share

COinS
 

Improving Perioperative Outcomes and Reducing Opioid Use with Dexmedetomidine as a Neuraxial Adjunct: Provider Education

Background

Inadequate post-operative pain management and the rising use of opioids as a remedy are some of the most significant barriers to optimal perioperative outcomes for many patients. Using Dexmedetomidine as a neuraxial adjunct to optimize post-operative pain and reduce opioid use is one of the latest developments in anesthesia to combat this issue.

Objective

This quality improvement project aimed to develop an educational intervention to increase CRNA awareness about the growing anesthetic technique of neuraxial Dexmedetomidine, improving their knowledge and comfort in adopting a technique that reduces opioid consumption.

Design

CRNAs completed a pre-survey to assess their knowledge of using Dexmedetomidine as a neuraxial adjunct. Participants then attended educational sessions outlining the latest evidence supporting the practice. A posttest followed the sessions to assess changes in knowledge and the likelihood of CRNAs incorporating this newer technique within their practice.

Results

CRNAs demonstrated an increase in their knowledge about the mechanism through which neuraxial Dexmedetomidine improves the perioperative experience and reduces opioid consumption. Most participants reported a high likelihood of adopting this technique within their practice.

Conclusion

Current literature suggests that Dexmedetomidine as a neuraxial adjunct has the potential to transform perioperative experiences as we move to opioid-sparing techniques. The educational sessions to disseminate the upcoming technique effectively increased the awareness and practice knowledge of all the learners involved to continue improving patient outcomes.

KEYWORDS: intrathecal Dexmedetomidine, epidural Dexmedetomidine, opioid-sparing analgesia, provider education